TSX: CMED $11.36 20 Minute Delay -0.42 ( -3.56% ) Volume: 22,264 October 19, 2017

The investment firms and equity analysts listed below provide research reports on CanniMed Therapeutics Inc. (CanniMed).

Opinions, estimates, forecasts or other analyses, including prior or future CanniMed performance from any source, is the opinion of the writer and is theirs alone and does not represent the opinions, estimates or forecasts of CanniMed or its management. CanniMed does not, by any reference below, imply any endorsement of, or concurrence with, such information, conclusions or recommendations.

CanniMed does not distribute research reports, and this list is current to the best of the Company's knowledge.

Firm Location Analyst
AltaCorp Toronto, Canada Keith Carpenter, 647 776-8240
kcarpenter@altacorpcapital.com
Clarus Securities Inc. Toronto, Canada Noel Atkinson, 416 343-3352
natkinson@clarussecurities.com
Cormark Securities Inc. Toronto, Canada Jesse Pytlak, 416 943-4223
jpytlak@cormark.com
Echelon Partners Toronto, Canada Russell Stanley, 647 794-1922
rstanley@echelonpartners.com
Haywood Securities Inc. Toronto, Canada Neal Gilmer, 416 507-2759
ngilmer@haywood.com
Mackie Research Capital Corporation Toronto, Canada Greg McLeish, 416 860-8633
gmcleish@mackieresearch.com